awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38365938-1C49AA12-DA2B-4A1E-AA50-08A9A2FA7F02
Q38365938-1C49AA12-DA2B-4A1E-AA50-08A9A2FA7F02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38365938-1C49AA12-DA2B-4A1E-AA50-08A9A2FA7F02
Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.
P2860
Q38365938-1C49AA12-DA2B-4A1E-AA50-08A9A2FA7F02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38365938-1C49AA12-DA2B-4A1E-AA50-08A9A2FA7F02
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8dd89b869a5d68292d046390266c2ea62c36dcb7
P2860
Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.